Published in Viruses on August 29, 2012
HIV-1 transcription and latency: an update. Retrovirology (2013) 1.49
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression. PLoS Pathog (2015) 1.18
Cellular and molecular mechanisms involved in the establishment of HIV-1 latency. Retrovirology (2013) 1.18
Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription. J Biol Chem (2013) 1.17
Viral-host interactions that control HIV-1 transcriptional elongation. Chem Rev (2013) 0.93
SIV replication is directly downregulated by four antiviral miRNAs. Retrovirology (2013) 0.89
HIV-1 latency: an update of molecular mechanisms and therapeutic strategies. Viruses (2014) 0.89
Recent developments in human immunodeficiency virus-1 latency research. J Gen Virol (2013) 0.87
MicroRNA-mediated regulation of p21 and TASK1 cellular restriction factors enhances HIV-1 infection. J Cell Sci (2015) 0.85
Molecular mechanisms of HIV latency. J Clin Invest (2016) 0.85
RNA viruses and microRNAs: challenging discoveries for the 21st century. Physiol Genomics (2013) 0.84
Promoter Targeting RNAs: Unexpected Contributors to the Control of HIV-1 Transcription. Mol Ther Nucleic Acids (2015) 0.81
Reactivation of latent HIV: do all roads go through P-TEFb? Future Virol (2013) 0.81
miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection. J Biol Chem (2015) 0.81
Mechanism and factors that control HIV-1 transcription and latency activation. J Zhejiang Univ Sci B (2014) 0.79
HLA-G/C, miRNAs, and their role in HIV infection and replication. Biomed Res Int (2013) 0.79
Bioinformatics and HIV latency. Curr HIV/AIDS Rep (2015) 0.78
Roles of microRNAs and long-noncoding RNAs in human immunodeficiency virus replication. Wiley Interdiscip Rev RNA (2015) 0.78
HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA. PLoS One (2015) 0.76
The impact of microRNAs on protein output. Nature (2008) 32.39
Widespread changes in protein synthesis induced by microRNAs. Nature (2008) 31.44
Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature (2010) 22.04
Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell (2010) 17.87
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell (1990) 17.60
Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature (2009) 14.07
Development of monocytes, macrophages, and dendritic cells. Science (2010) 12.86
Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21
Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science (2008) 11.33
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature (2005) 11.12
MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell (2007) 9.33
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature (2011) 9.30
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med (2009) 8.45
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature (2011) 7.92
Monocyte recruitment during infection and inflammation. Nat Rev Immunol (2011) 7.55
T cell activation. Annu Rev Immunol (2009) 7.40
T cell anergy. Annu Rev Immunol (2001) 7.15
Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med (1995) 6.50
Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med (2007) 6.01
Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell (2010) 5.77
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol (2012) 5.71
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol (2002) 5.49
miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One (2007) 5.43
MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet (2012) 5.38
HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature (2011) 5.28
Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science (2007) 5.07
MicroRNA profiling of the murine hematopoietic system. Genome Biol (2005) 4.94
Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol (2009) 4.32
miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A (2007) 4.15
Target RNA-directed trimming and tailing of small silencing RNAs. Science (2010) 3.98
LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science (1997) 3.77
Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science (2010) 3.45
HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity (2001) 3.43
Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell (2010) 3.42
Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J Biol Chem (2011) 3.21
Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell (2009) 3.05
Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood (2008) 2.96
HIV latency. Cold Spring Harb Perspect Med (2011) 2.90
Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J Virol (2002) 2.89
Pol II waiting in the starting gates: Regulating the transition from transcription initiation into productive elongation. Biochim Biophys Acta (2010) 2.86
Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J Virol (1995) 2.85
Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol (1996) 2.75
HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med (2010) 2.71
The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature (2003) 2.63
Regulation of quiescence in lymphocytes. Trends Immunol (2003) 2.58
Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J Virol (2005) 2.55
Kinetic analysis reveals the fate of a microRNA following target regulation in mammalian cells. Curr Biol (2011) 2.53
IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol (2011) 2.44
Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat Immunol (2001) 2.36
Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J Virol (1994) 2.36
A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe (2009) 2.34
Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome Res (2011) 2.34
Chromatin poises miRNA- and protein-coding genes for expression. Genome Res (2009) 2.28
Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli. J Virol (2005) 2.23
MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol (2011) 2.15
Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol (2011) 2.11
The control of HIV transcription: keeping RNA polymerase II on track. Cell Host Microbe (2011) 2.05
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology (2009) 2.02
Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes. J Virol (1999) 1.97
Metabolism in T cell activation and differentiation. Curr Opin Immunol (2010) 1.97
MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology (2008) 1.96
miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog (2009) 1.94
Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology (2008) 1.87
Human cellular restriction factors that target HIV-1 replication. BMC Med (2009) 1.86
CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol (1998) 1.85
Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol (1998) 1.83
Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS (2001) 1.82
Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques. Proc Natl Acad Sci U S A (2005) 1.75
RNA virus microRNA that mimics a B-cell oncomiR. Proc Natl Acad Sci U S A (2012) 1.75
Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Chem (1983) 1.74
Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA (2010) 1.66
The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology (2010) 1.64
In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells. J Virol (2003) 1.63
Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 1.63
Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology (2012) 1.62
Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J Virol (2001) 1.60
Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors. J Biol Chem (1995) 1.58
The metabolic life and times of a T-cell. Immunol Rev (2010) 1.57
Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J Virol (2004) 1.52
Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients. J Clin Invest (1991) 1.52
Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host Microbe (2009) 1.52
Long HIV type 1 reverse transcripts can accumulate stably within resting CD4+ T cells while short ones are degraded. AIDS Res Hum Retroviruses (2004) 1.51
Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines. J Virol (2001) 1.48
Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood (2011) 1.47
MicroRNA-125b potentiates macrophage activation. J Immunol (2011) 1.47
Human immunodeficiency virus integrates directly into naive resting CD4+ T cells but enters naive cells less efficiently than memory cells. J Virol (2009) 1.45
Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells. J Virol (2007) 1.45
Suppression of HIV-1 replication by microRNA effectors. Retrovirology (2009) 1.44
Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1. J Virol (2008) 1.41
Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathog (2012) 1.40
The potential of CD4 T-cell memory. Immunology (2010) 1.40
Interplay between HIV-1 infection and host microRNAs. Nucleic Acids Res (2011) 1.36
Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology (2010) 1.33
Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes. J Virol (2011) 1.32
Macrophage polarization and HIV-1 infection. J Leukoc Biol (2009) 1.32
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. J Virol (2007) 1.31
An enigmatic tail of CD28 signaling. Cold Spring Harb Perspect Biol (2010) 1.30
Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA. J Infect Dis (2012) 1.30
Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function. J Virol (2002) 1.29
HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy. J Infect Dis (2012) 1.29
miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog (2009) 1.94
Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes. J Virol (2011) 1.32
Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function. J Virol (2002) 1.29
Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-loop. J Biol Chem (2008) 1.23
Characterization of Cdk9 T-loop phosphorylation in resting and activated CD4(+) T lymphocytes. J Leukoc Biol (2009) 1.19
Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells. Retrovirology (2006) 1.17
Identification of LKLF-regulated genes in quiescent CD4+ T lymphocytes. Mol Immunol (2005) 1.16
The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting Scribble. J Virol (2010) 1.13
Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses. J Virol (2011) 1.12
Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology (2009) 1.09
Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells. J Virol (2012) 1.08
The avian influenza virus NS1 ESEV PDZ binding motif associates with Dlg1 and Scribble to disrupt cellular tight junctions. J Virol (2011) 1.07
Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis. Virology (2006) 1.06
Cyclin T1 but not cyclin T2a is induced by a post-transcriptional mechanism in PAMP-activated monocyte-derived macrophages. J Leukoc Biol (2005) 1.04
Increased association of 7SK snRNA with Tat cofactor P-TEFb following activation of peripheral blood lymphocytes. AIDS (2003) 1.03
Induction of the HIV-1 Tat co-factor cyclin T1 during monocyte differentiation is required for the regulated expression of a large portion of cellular mRNAs. Retrovirology (2006) 1.03
Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors. PLoS One (2008) 1.01
T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes. J Cell Physiol (2010) 1.00
Human immunodeficiency virus type 1 infection induces cyclin T1 expression in macrophages. J Virol (2004) 0.99
siRNA depletion of 7SK snRNA induces apoptosis but does not affect expression of the HIV-1 LTR or P-TEFb-dependent cellular genes. J Cell Physiol (2005) 0.99
miR-132 enhances HIV-1 replication. Virology (2013) 0.98
Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes. J Virol (2006) 0.95
Cdk9 T-loop phosphorylation is regulated by the calcium signaling pathway. J Cell Physiol (2012) 0.92
Mini ways to stop a virus: microRNAs and HIV-1 replication. Future Virol (2011) 0.90
Phosphatase PPM1A negatively regulates P-TEFb function in resting CD4(+) T cells and inhibits HIV-1 gene expression. Retrovirology (2012) 0.88
55K isoform of CDK9 associates with Ku70 and is involved in DNA repair. Biochem Biophys Res Commun (2010) 0.88
The influenza A virus protein NS1 displays structural polymorphism. J Virol (2014) 0.86
Isolation and characterization of the human DC-SIGN and DC-SIGNR promoters. Gene (2003) 0.86
Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One (2011) 0.86
HIV-1 infection and regulation of Tat function in macrophages. Int J Biochem Cell Biol (2004) 0.83
Limited redundancy in genes regulated by Cyclin T2 and Cyclin T1. BMC Res Notes (2011) 0.82
Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function. Retrovirology (2012) 0.82
Short communication: SAHA (vorinostat) induces CDK9 Thr-186 (T-loop) phosphorylation in resting CD4+ T cells: implications for reactivation of latent HIV. AIDS Res Hum Retroviruses (2015) 0.81
Regulation of interferon-β by MAGI-1 and its interaction with influenza A virus NS1 protein with ESEV PBM. PLoS One (2012) 0.77
Dysregulation of positive transcription elongation factor B and myocardial hypertrophy. Circ Res (2009) 0.76
Pressure catalyzed bond dissociation in an anthracene cyclophane photodimer. J Am Chem Soc (2012) 0.75